【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, November 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, November 2013 14
2.2.1 Shire to Acquire ViroPharma for US$4.2 Billion 14
2.2.2 Salix Pharma Commences Cash Tender Offer to Acquire Santarus for US$2.6 Billion 15
2.2.3 Perrigo Completes Private Placement of Notes for US$2.3 Billion 16
2.2.4 CVS Caremark to Acquire Coram from Apria Healthcare for US$2.1 Billion 16
2.2.5 Mylan Completes Public Offering of Notes for US$2 Billion 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, November 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, November 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2013 20
3.1.1 Top M&A Deals in November 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, June 2013 – November 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, November 2013 25
3.2.1 Top Equity Offering Deals in November 2013 27
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, June 2013 – November 2013 28
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, November 2013 30
3.3.1 Top PE/VC Deals in November 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, November 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, November 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2013-November 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2013-November 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, June 2013 – November 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), November 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, November 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, June 2013 – November 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), June 2013 – November 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), November 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, November 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, November 2013 57
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, November 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), June 2013 – November 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), June 2013 – November 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, November 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, November 2013 70
6.2.1 Central Nervous System – Deals of the Month 72
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, November 2013 74
6.3.1 Immunology – Dealsof the Month 76
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, November 2013 77
6.4.1 Cardiovascular – Deal of the Month 79
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, November 2013 81
6.5.1 Infectious Diseases – Deals of the Month 83
6.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, November 2013 84
6.6.1 Metabolic Disorders – Deal of the Month 86
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, November 2013 88
6.7.1 Gastrointestinal – Deal of the Month 90
7 Deal Summary by Geography 91
7.1 Pharmaceuticals & Healthcare, North America Deals, November 2013 91
7.1.1 North America – Deals of the Month 93
7.2 Pharmaceuticals & Healthcare, Europe, Deals, November 2013 95
7.2.1 Europe – Deals of the Month 96
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, November 2013 98
7.3.1 Asia-Pacific – Deals of the Month 100
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, November 2013 101
7.4.1 Rest of the World – Deals of the Month 102
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 103
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, June 2013 – November 2013 103
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, June 2013 – November 2013 105
9 Further Information 107
9.1 Methodology 107
9.2 About GlobalData 108
9.3 Disclosure information 109
9.4 Disclaimer 109
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：November 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for November 2013 in Pharmaceuticals
■ 発行日：2013年12月15日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163262
■ 調査対象地域：グローバル
- オペレーション業務BPaaS（クラウド型ビジネスプロセスサービス）の世界市場Operation BPaaS is a part of Business Process as a Service (BPaaS), which assists companies in outsourcing their operational activities. BPaaS is delivered based on a cloud services model, wherein the different cloud services include Software as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS). BPaaS is highly service-oriented and has well-defined interfaces. …
- 世界の生物活性材料及び製品（Bioactive Ingredients & Product）市場動向と予測（～2018）The market for bioactive ingredients is projected to experience a growth rate of 7.2% by 2018 to touch $33.6 billion. This estimation is attributed to the widening bioactive industry, which is a result of increased consumer awareness and health concerns. The Asia-Pacific region is the dominant market with increasing population, urbanization, and disposable income in countries such as India, China, …
- Telemedicine – The Future is Now for Moving Telemedicine into Mainstream TreatmentTelemedicine is a creation of the 20th century. First used primarily for military and space applications, it has been becoming more widespread in use in recent years. There are three main types of telemedicine applications: store-and-forward, remote monitoring and interactive services. Interest in telemedicine is growing globally, particularly in the fields of teleradiology, telepathology and tele …
- 低温ポンプの世界市場：遠心式ポンプ、容積式ポンプThe cryogenic pump market is expected to reach USD 1.96 Billion by 2021, at a CAGR of 3.28% from 2016 to 2021. The growth of this market is attributed to increasing demand for LNG from sectors such as power generation and domestic & commercial fuel and demand for medical gases in healthcare facilities. Moreover, the global cryogenic pump market is projected to witness high growth on account of ris …
- 世界における貧血症/ビタミン検査製品のパイプライン動向2015Anemia / Vitamin Tests - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Anemia / Vitamin Tests - Pipeline Review, 2015" provides an overview of Anemia / Vitamin Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major play …
- 世界のインシュリン市場動向2018About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has remained as a standard treatment for both Type I diabetes. Owing to the growing prevalence of diabetes and progressive nature of the d …
- 石油・ガス産業向けSCADAの世界市場About SCADA SCADA is an automation system that helps to acquire data from remote devices such as transmitters, pumps, and valves, installed in the field and provides control remotely from SCADA host software platform. It helps to turn on and off the devices according to the required process. It also has graphic displays, trending, alarming, and historical storage of data functionalities. Earlier, …
- 自動車用エアレスラジアルタイヤの世界市場2017-2021About Airless Radial Tire The design of airless tires is quite apparent when the above introductory note is read. Since they do not require air pressure as a supporting element, airless tires have their other supporting structures made of polymers. These tires are available in different designs, and the type of design dictates the choice of filler material that acts as a buffering material. Techna …
- End-to-End M2M Fourth EditionMachine-to-machine (M2M) communications is an emerging technology and industry sub-segment poised to change the way that business is conducted, impacting everything from traditional telephony and IT operations to ERP, SCM, public safety, homeland security, and more. Written by industry experts who have actually designed, implemented and operated M2M applications, End-to-End M2M Fourth Edition prov …
- エチレンオキシド及びエチレングリコールの世界市場2016-2020About Ethylene Oxide and Ethylene Glycol Ethylene oxide is a chemically reactive material. It is used for manufacturing ethylene glycols, glycol ethers, ethanolamines, surface-active agents, and polyether polyols. Ethylene glycol is a clear, viscous, versatile organic compound that is a hydroscopic liquid at room temperature. It is used in the manufacture of polyester films, fibers and PET resins, …
- インフラソリューション及びインテグレーションサービスの世界市場Infrastructure Solution and Integration Services includes any kind of solution or service that requires running the business operation of any organization or industry. Infrastructure Solution and Integration Services are used right from production to the last mile delivery of a product. Infrastructure Solution and Integration Services provides facilities like Storage, Server, Software Development …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- 睡眠無呼吸症用医療機器の世界市場：睡眠無呼吸治療デバイス、睡眠無呼吸診断デバイスThe global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of s …
- Wisconsin Energy Corporation：発電所及び企業SWTO分析2015Wisconsin Energy Corporation - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summa …
- 民間航空機用着陸装置の世界市場2015-2019About Commercial Aircraft Landing Gear Landing gears are one of the most important subsystems installed on an aircraft. They support the entire weight of an aircraft during takeoff and landing, and also during ground operations. The commercial aircraft landing gears are highly advanced and sophisticated systems, and comprise modern control and steering mechanisms. Landing gears also consist of sho …
